FindMyRecallSubscribe
Class I: serious health riskTerminated

American Lifestyle.Com Vicerex A Powerful And Fast Acting Male Recall

Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary S…

American Lifestyle.Com · Pittsford, NY

Risk level
Class I
Reported by FDA
Apr 16, 2014
Recall ID
D-1223-2014
Check your lot numberHow we source this data

Summary

American Lifestyle.Com recalled Vicerex A Powerful And Fast Acting Male starting Apr 30, 2013. The FDA classified it as Class I (serious health risk) and published enforcement report D-1223-2014 on Apr 16, 2014. Reason: Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs. Status: Terminated.

Why it was recalled

Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.

Product description

Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Supplement. UPC 893490820087 (product numbers may possibly vary for same product identification and same product packaging), distributed by Vicerex.com.

Lot numbers, UPCs & expiration codes

All lots, UPC 893490820087

Where it was sold

Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Venezuela, Oman.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1223-2014
Classification
Class I
Status
Terminated
Recall initiated
Apr 30, 2013
FDA report date
Apr 16, 2014
Quantity
13 boxes distributed domestically & 50 boxes distributed internationally to consumers
Recall type
Voluntary: Firm initiated
Recalling firm
American Lifestyle.Com

Original FDA data

Every field from FDA enforcement report D-1223-2014, exactly as published.

Show all FDA fields
City
Pittsford
State
NY
Status
Terminated
Country
United States
Event ID
65095
Address
640 Kreag Rd Ste 101
Code information
All lots, UPC 893490820087
Postal code
14534-3737
Report date
Apr 16, 2014
Product type
Drugs
Recall number
D-1223-2014
Classification
Class I
Recalling firm
American Lifestyle.Com
Product quantity
13 boxes distributed domestically & 50 boxes distributed internationally to consumers
Termination date
Jun 27, 2018
Reason for recall
Marketed without an Approved NDA/ANDA: Laboratory analysis conducted by the FDA has determined the Vicerex product contains undeclared tadalafil and the Black Ant product contains undeclared sildenafil. Tadalafil and sildenafil are FDA-Approved drugs used to treat male erectile dysfunction (ED), making the Vicerex and the Black Ant products unapproved new drugs.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Vicerex A Powerful And Fast Acting Male Sexual Enhancer, 10 capsules per box, Dietary Supplement. UPC 893490820087 (product numbers may possibly vary for same product identification and same product packaging), distributed by Vicerex.com.
Distribution pattern
Domestic distribution currently under Investigation; International distribution includes, but may not be limited to the following countries : Mexico, France, Brazil, Belgium, Denmark, Switzerland, Spain, Canada, Italy, Japan, Ireland, Venezuela, Oman.
Recall initiation date
Apr 30, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Apr 7, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1223-2014, published Apr 16, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls